Amblyopia, Strabismus May Slow Test Performance in Children

Share this content:
Amblyopia, Strabismus May Slow Test Performance in Children
Amblyopia, Strabismus May Slow Test Performance in Children

THURSDAY, June 14, 2018 (HealthDay News) -- Children with certain eye conditions -- amblyopia or strabismus -- require more time to fill out multiple-choice answer forms, according to a study published online June 14 in JAMA Ophthalmology.

Krista R. Kelly, Ph.D., from the Retina Foundation of the Southwest in Dallas, and colleagues assessed multiple-choice answer form completion time, an academic-related fine motor outcome, in 65 children (mean grade completed, 3.42) with amblyopia and strabismus and 20 control children with normal visual acuity and stereoacuity and no history of vision disorders.

The researchers found that, compared with children in the control group, children with amblyopia had a slower mean time to completion (P = 0.001), as did children with non-amblyopic strabismus (P = 0.002). Children with these eye conditions required approximately 28 percent more time to fill out a multiple-choice answer form. There was no association between completion time and etiology, visual acuity, or stereoacuity.

"Longer completion time in children with amblyopia or strabismus may affect a child's performance on tests using multiple-choice answer forms and may hinder academic success," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »